The insider sales are too small to be a meaningful signal. Focus on the Q2 beat and Cortrophin Gel trajectory — the narrowed guidance for Cortrophin is the key risk to monitor. Given the stock's recent underperformance per historical calibration, consider waiting for a pullback before adding long exposure.
Price Chart
Executive Summary
Two ANIP insiders sold a combined $281K in open-market sales over a 7-day window following a strong Q2 earnings beat. The sales are small relative to the $1.7B market cap (0.017%), and the cluster is likely driven by post-earnings blackout window opening and routine portfolio diversification rather than a bearish signal. The earnings beat and reaffirmed guidance provide a positive backdrop, but the insider sales temper the bullish read.
Key Financial Metrics
Key Facts
- Two insiders sold a total of $281K in open-market sales from Aug 6-13, 2026.
- Sales represent 0.017% of ANIP's $1.7B market cap — well below the 0.1% materiality threshold.
- Q2 2026 revenue of $266.0M (+25.9% YoY) beat consensus of $260.1M; adjusted EPS of $2.21 beat $2.04 estimate.
- Cortrophin Gel revenue surged 43.5% to $117.1M, but full-year Cortrophin guidance was narrowed to $520-$540M from $540-$575M.
- Historical performance on ANIP reports shows a 30% win rate at T+20 with average alpha of -2.72%, suggesting prior bullish calls have underperformed.
Financial Impact
Insider sales of $281K, or 0.017% of market cap — immaterial in absolute and relative terms.
Risk Factors
- Cortrophin Gel guidance narrowed to $520-$540M from $540-$575M, signaling potential demand deceleration.
- Historical reports on ANIP show a 30% win rate at T+20 with negative alpha, suggesting the stock has been difficult to trade directionally.
- Insider sales, while small, could indicate insiders are taking advantage of the post-earnings price strength.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ANIP-1786691014960 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $72.11 $77.91 | ▲ +8.04% | ▲ +7.23% | $71.97 (−0.19%) |
Sep 1, 2026 4w ago | Insider Cluster | $73.06 $71.46 | ▼ −2.19% | ▼ −1.23% | $71.97 (−1.49%) |
Aug 24, 2026 5w ago | 8-K | $74.17 $73.25 | ▼ −1.24% | ▼ −1.71% | $71.97 (−2.97%) |
Aug 13, 2026 7w ago | Insider Cluster | $74.77 $77.32 | ▲ +3.41% | ▲ +5.37% | $71.97 (−3.74%) |
Aug 7, 2026 8w ago | 8-K | $78.25 $76.54 | ▼ −2.19% | ▼ −2.58% | $71.97 (−8.03%) |
Jul 16, 2026 11w ago | Court Ruling | $81.92 $78.53 | ▼ −4.14% | ▼ −2.47% | $71.97 (−12.15%) |
Jul 13, 2026 11w ago | Press Release | $81.08 $79.20 | ▼ −2.32% | ▼ −1.53% | $71.97 (−11.24%) |
Jun 15, 2026 15w ago | Insider Cluster | $83.00 $82.94 | ▼ −0.07% | ▲ +2.16% | $71.97 (−13.29%) |
Jun 11, 2026 16w ago | Insider Cluster | $81.65 $80.52 | ▼ −1.38% | ▼ −1.82% | $71.97 (−11.86%) |
May 21, 2026 19w ago | 8-K | $82.72 $76.71 | ▼ −7.27% | ▼ −8.92% | $71.97 (−13.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access